Insider Trading activities at Molecular Insight Pharmaceuticals, Inc. (MIPI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Molecular Insight Pharmaceuticals, Inc. (MIPI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Molecular Insight Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1340752.

Total stock buying since 2010: $0.
Total stock sales since 2010: $56,931.
Total stock option exercises since 2010: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


1 insider reported insider trading activities at Molecular Insight Pharmaceuticals, Inc. (MIPI):
Insider trading activities of Barlow David S

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Molecular Insight Pharmaceuticals, Inc. (MIPI).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2011 0 $0 97,000 $16,031 0 $0
2010 0 $0 200,000 $40,900 0 $0

Table 2. Monthly summary of insider trading at Molecular Insight Pharmaceuticals, Inc. (MIPI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-01 0 $0 97,000 $16,031 0 $0
2010-12 0 $0 200,000 $40,900 0 $0

Table 3. Detailed insider trading at Molecular Insight Pharmaceuticals, Inc. (MIPI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-01-28 Barlow David S (10% Owner) Sale 59,000 .16 9,381
2011-01-27 Barlow David S (10% Owner) Sale 38,000 .17 6,650
2010-12-17 Barlow David S (10% Owner) Sale 155,000 .20 31,000
2010-12-16 Barlow David S (10% Owner) Sale 45,000 .22 9,900

Insider trading activities including stock purchases, stock sales, and option exercises of MIPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Molecular Insight Pharmaceuticals, Inc. (symbol MIPI, CIK number 1340752) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.